SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): August 12, 2010
 
 
EARTH SEARCH SCIENCES, INC.
(Exact name of registrant as specified in Charter)

 
Nevada
 
000-19566
 
87-0437723
(State or other jurisdiction of
incorporation or organization)
 
(Commission File No.)
 
(IRS Employee Identification No.)
 


306 Stoner Loop Road, Lakeside, MT 59922
(Address of Principal Executive Offices )

(406) 751-5200
(Issuer Telephone number)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 

 
Section 4 — Matters Related to Accountants and Financial Statements

Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

While preparing Earth Search Sciences, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, the Company became aware of prior period misstatements related to the capitalization of research and development costs.
 
Based on this discovery and the conclusion made by Management, as described below, the Annual Reports for the periods ended March 31, 2010 and March 31 2009, and the Quarterly Reports for the periods ended December 31, 2009, September 30, 2009, June 30, 2009, December 30, 2008 and September 30, 2008 should not be relied upon and should be restated.
 
The purpose of this filing is to disclose the restatements of the affected periods (annual periods ended March 31, 2010 and March 31, 2009 and quarterly periods ended December 31, 2009, September 30, 2009, June 30, 2009, December 31, 2008 and September 30, 2008) under Item 4.02 of Form 8-K.  No further restatement of the Company’s financials is anticipated.
 
Decision to Restate and Effect of the Restatement
On August 13, 2010, during the Company’s quarter-end close procedures, MaloneBailey LLP, the Company’s registered independent public accounting firm, discovered and informed the Company of an error related to the capitalization of the costs for our Prototype development.  Beginning in the quarter ended September 30, 2008, the Company capitalized all costs associated with the development of our prototype in the belief it should be treated as the construction of equipment. Upon re-examination management has concluded that such costs should have been treated as research and development costs and expensed when occurred.
 

 
 

 


The following tables illustrate the impact of this error on the Company’s financial statements for the respective periods:

The twelve months ended March 31, 2010:

March 31, 2010
   
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Balance Sheet
           
Deposits
 
$
903,684
$
(903,684)
$
-
TOTAL ASSETS
   
1,045,771
 
(903,684)
 
142,087
             
-
Accumulated deficit
   
(73,105,699)
 
(903,684)
 
(74,009,383)
Total stockholders’ deficit
 
(17,898,081)
 
(903,684)
 
(18,801,765)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
 
1,045,771
 
(903,684)
 
142,087
               
               
For the Year Ended March 31, 2010
 
As
     
As
     
Reported
 
Adjustment
 
Restated
Consolidated Statement of Expenses
           
General and administrative
$
1,410,485
$
(10,832)
$
1,399,653
               
Total expenses
   
1,511,957
 
(10,832)
 
1,501,125
               
Loss from operations
   
(1,511,957)
 
(10,832)
 
(1,501,125)
               
Net Loss
   
(1,267,675)
 
(10,832)
 
(1,256,843)
               
For the Year Ended March 31, 2010
 
As
     
As
     
Reported
 
Adjustment
 
Restated
Consolidated Statements of Cash Flows
           
Net loss
 
$
(1,267,675)
$
(10,832)
$
(1,256,843)
               
Accounts payable and accrued expenses
 
861,374
 
(140,832)
 
720,542
NET CASH USED IN OPERATING ACTIVITIES
 
(655,793)
 
(140,832)
 
(785,793)
               
Cash paid for prototype
 
(130,000)
 
130,000
 
-
NET CASH USED IN INVESTING ACTIVITIES
 
(130,000)
 
130,000
 
-
               
Capitalized prototype cost in accounts payable
 
10,832
 
(10,832)
 
-
               
For the Year Ended March 31, 2010
 
As
     
As
     
Reported
 
Adjustment
 
Restated
Consolidated Statement of Changes in Stockholders' deficit
           
               
Net Loss
 
 $
(1,267,675)
 
(10,832)
$
(1,256,843)
Accumulated deficit
   
(73,105,699)
 
(903,684)
 
(74,009,383)
Total stockholders’ deficit
 
(17,898,081)
 
(903,684)
 
(18,801,765)



 
 

 

The nine months ended December 31, 2009:

December 31, 2009
   
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Balance Sheet
           
Deposits
 
$
887,076
$
(887,076)
$
-
TOTAL ASSETS
   
1,062,560
 
(887,076)
 
175,484
               
Accumulated deficit
   
(72,684,512)
 
(887,076)
 
(73,571,588)
               
Total stockholders’ deficit
 
(17,465,657)
 
(887,076)
 
(18,352,733)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
 
1,062,560
 
(887,076)
 
175,484
               
               
For the Year Ended December 31, 2009
 
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Statement of Expenses
           
               
General and administrative
$
1,121,375
$
(27,440)
$
1,093,935
               
Total expenses
   
1,199,261
 
(27,440)
 
1,171,821.00
               
Loss from operations
   
(1,199,261)
 
27,440
 
(1,171,821)
               
Net loss
   
(846,486)
 
27,440
 
(819,046)
               
For the Year Ended December 31, 2009
 
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
               
CASH FLOWS FROM OPERATING ACTIVITIES
           
Net loss
 
$
(846,486)
$
27,440
$
(819,046)
Accounts payable and accrued expenses
 
715,214
 
(122,440)
 
592,774
    Cash paid for equipment
 
(95,000)
 
95,000
 
-
 Deposit included in account payable
 
27,440
 
(27,440)
 
-
     Prepaid compensation in account payable
 
-
       
               
For the Year Ended December 31, 2009
 
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Statement of Changes in Stockholders' deficit
           
               
Balances at March 31, 2009
$
(71,838,024)
$
(914,516)
$
(72,752,540)
Net Loss
   
(270,822)
 
27,440
 
(243,382)
Accumulated deficit
   
(72,108,846)
 
(887,076)
 
(72,995,922)
Total stockholders’ deficit
 
(17,465,657)
 
(887,076)
 
(18,352,733)


 
 

 

The six months ended September 30, 2009:

September 30, 2009
   
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Balance Sheet
           
Deposits
 
$
887,076
$
(887,076)
$
-
TOTAL ASSETS
   
989,624
 
(887,076)
 
102,548
Accumulated deficit
   
(72,108,846)
 
(887,076)
 
(72,995,922)
               
Total stockholders’ deficit
 
(16,990,872)
 
(887,076)
 
(17,877,948)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
 
989,624
 
(887,076)
 
102,548
               
For the Period Ended September 30, 2009
 
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Statement of Expenses
           
               
General and administrative
$
717,046
$
(27,440)
$
689,606
               
Total expenses
   
768,970
 
(27,440)
 
741,530
               
Loss from operations
   
(768,970)
 
27,440
 
(741,530)
               
Net income/(loss)
   
(270,822)
 
27,440
 
(243,382)
               
For the Year Ended September 30, 2009
 
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Statements of Cash Flows
           
               
Net loss
 
$
(270,822)
$
27,440
$
(243,382)
Accounts payable and accrued expenses
 
501,116
 
(72,440)
 
428,676
    Cash paid for equipment
 
(45,000)
 
45,000
 
-
NET CASH USED IN INVESTING ACTIVITIES
 
(45,000)
 
45,000
 
-
               
 Deposit included in account payable
 
27,440
 
(27,440)
 
-
               
For the Six months ended September 30, 2009
 
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Statement of Changes in Stockholders' deficit
           
               
Balances at March 31, 2009
$
(71,838,024)
$
(914,516)
$
(72,752,540)
Net Loss
   
(270,822)
 
27,440
 
(243,382)
Accumulated deficit
   
(72,108,846)
 
(887,076)
 
(72,995,922)
               
Total stockholders’ deficit
 
(16,990,872)
 
(887,076)
 
(17,877,948)


 
 

 

The three months ended June 30, 2009:

June 30, 2009
   
 As
     
 As
 
     
 Reported
 
 Adjustment
 
 Restated
 
Consolidated Balance Sheet
             
Deposits
 
$
887,076
$
(887,076)
$
-
 
TOTAL ASSETS
   
1,082,240
 
(887,076)
 
195,164
 
Accumulated deficit
   
(72,437,860)
 
(887,076)
 
(73,324,936)
 
                 
Total stockholders’ deficit
 
(19,053,136)
 
(887,076)
 
(19,940,212)
 
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
 
1,082,240
 
(887,076)
 
195,164
 
                 
For the Period Ended June 30, 2009
 
 As
     
 As
 
     
 Reported
 
 Adjustment
 
 Restated
 
Consolidated Statement of Expenses
             
General and administrative
$
392,282
$
(27,440)
$
364,842
 
                 
Total expenses
   
418,244
 
(27,440)
 
390,804
 
                 
Loss from operations
   
(418,244)
 
27,440
 
(390,804)
 
                 
Net loss
   
(599,836)
 
27,440
 
(572,396)
 
                 
For the Year Ended June 30, 2009
 
As
     
 As
 
     
Reported
 
 Adjustment
 
 Restated
 
Consolidated Statements of Cash Flows
             
               
Accounts payable and accrued expenses
$
203,951
$
(35,000)
$
168,951
 
NET CASH USED IN OPERATING ACTIVITIES
 
(222,018)
 
(35,000)
 
(257,018)
 
    Cash paid for prototype
 
(35,000)
 
35,000
 
-
 
NET CASH USED IN OPERATING ACTIVITIES
 
(35,000)
 
35,000
 
-
 
                 
For the Three Months Ended June 30, 2010
 
 As
     
 As
 
     
 Reported
 
 Adjustment
 
 Restated
 
Consolidated Statement of Changes in Stockholders' deficit
             
                 
Balances at March 31, 2009
$
(71,838,024)
$
(914,516)
$
(72,752,540)
 
Net Loss
   
(270,822)
 
27,440
 
(243,382)
 
Accumulated deficit
   
(72,437,860)
 
(887,076)
 
(73,324,936)
 
Total stockholders’ deficit
 
(19,053,136)
 
(887,076)
 
(19,940,212)
 



 
 

 

The twelve months ended March 31, 2009:

March 31, 2009
   
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Balance Sheet
           
Deposits
 
$
914,516
$
(914,516)
$
-
TOTAL ASSETS
   
1,143,696
 
(914,516)
 
229,180
             
-
Accumulated deficit
   
(71,838,024)
 
(914,516)
 
(72,752,540)
Total stockholders’ deficit
 
(18,528,300)
 
(914,516)
 
(19,442,816)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
 
1,143,696
 
(914,516)
 
229,180
               
               
For the Year Ended March 31, 2009
 
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Statement of Expenses
           
Research and development expense
$
-
$
914,516
$
914,516
               
Total expenses
   
7,841,381
 
914,516
 
8,755,897
               
Loss from operations
   
-7,841,381
 
914,516
 
(8,755,897)
               
Net Loss
   
(8,496,248)
 
(914,516)
 
(9,410,764)
               
Basic and diluted:
             
Loss per share
   
(0.05)
 
(0.01)
 
(0.06)
               
               
For the Year Ended March 31, 2009
 
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Statements of Cash Flows
           
Net loss
 
$
(8,496,248)
$
(914,516)
$
(9,410,764)
Accounts payable and accrued expenses
 
511,231
 
164,516
 
675,747
NET CASH USED IN OPERATING ACTIVITIES
 
(832,476)
 
(750,000)
 
(1,582,476)
               
Cash paid for prototype
 
(750,000)
 
750,000
 
-
NET CASH USED IN INVESTING ACTIVITIES
 
(770,000)
 
750,000
 
(20,000)
               
Capitalized prototype cost in accounts payable
 
162,460
 
(162,460)
 
-
               
For the Year Ended March 31, 2009
 
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Statement of Changes in Stockholders' deficit
           
               
Net Loss
 
$
(8,496,248)
$
(914,516)
$
(9,410,764)
Accumulated deficit
   
(71,838,024)
 
(914,516)
 
(72,752,540)
Total stockholders’ deficit
 
(18,528,300)
 
(914,516)
 
(19,442,816)


 
 

 

The nine months ended December 31, 2008:

December 31, 2008
   
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Balance Sheet
           
Deposits
 
$
914,517
$
(914,517)
$
-
TOTAL ASSETS
   
1,192,592
 
(914,517)
 
278,075
Accumulated deficit
   
(71,041,985)
 
(914,517)
 
(71,956,502)
               
Total stockholders’ deficit
 
(17,925,250)
 
(914,517)
 
(18,839,767)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
 
1,192,592
 
(914,517)
 
278,075
               
               
For the Year Ended December 31, 2008
 
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Statement of Expenses
           
               
  Research and development expense
$
-
$
914,517
$
914,517
Total expenses
   
7,241,339
 
914,517
 
8,155,856
               
Loss from operations
   
(7,241,339)
 
(914,517)
 
(8,155,856)
               
Net ( loss)
   
(7,700,209)
 
(914,517)
 
(8,614,726)
               
Basic and diluted:
             
Loss per share
   
(0.05)
 
(0.01)
 
(0.06)
               
For the Year Ended December 31, 2008
 
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Statements of Cash Flows
           
Net loss
 
$
(7,700,209)
$
(914,517)
$
(8,614,726)
Accounts payable and accrued expenses
 
27,044
 
192,460
 
219,504
Deposits
   
(722,057)
 
722,057
 
-
Deposit included in accounts payable
 
192,460
 
(192,460)
 
-
               
For the Year Ended December 31, 2008
 
As
     
As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Statement of Changes in Stockholders' deficit
           
               
Net ( loss)
 
$
(7,700,209)
$
(914,517)
$
(8,614,726)
Accumulated deficit
   
(71,041,985)
 
(914,517)
 
(71,956,502)
Total stockholders’ deficit
 
(17,925,250)
 
(914,517)
 
(18,839,767)






 
 

 

The six months ended September 30, 2008:

September 30, 2008
   
 As
     
 As
     
 Reported
 
 Adjustment
 
 Restated
Consolidated Balance Sheet
           
               
Deposits
 
$
771,937
$
(771,937)
$
                          -
TOTAL ASSETS
 
$
1,060,983
 
(771,937)
 
289,046
Accumulated deficit
   
(70,352,640)
 
(771,937)
 
(71,124,577)
Total stockholders’ deficit
 
(17,553,180)
 
(771,937)
 
(18,325,117)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
$
1,060,983
 
(771,937)
 
289,046
               
For the Period Ended September 30, 2008
 
As
     
As
     
Reported
 
Adjustment
 
Restated
Consolidated Statement of Expenses
           
               
Research and development expense
$
                          -
$
771,937
$
771,937
               
Total expenses
   
6,738,156
 
771,937
 
7,510,093
               
Loss from operations
   
(6,738,156)
 
771,937
 
(7,510,093)
               
Net income ( loss)
   
(7,010,864)
 
(771,937)
 
(7,782,801)
               
Loss per share
   
(0.05)
 
(0.01)
 
(0.06)
               
For the Period Ended September 30, 2008
 
As
     
As
     
Reported
 
Adjustment
 
Restated
Consolidated Statements of Cash Flows
           
CASH FLOWS FROM OPERATING ACTIVITIES
           
Net loss
 
$
(7,010,864)
$
(771,937)
$
(7,782,801)
Accounts payable and accrued expenses
 
(170,574)
 
119,881
 
(50,693)
Deposits
   
(652,056)
 
652,056
 
0
Deposit included in accounts payable
 
119,881
 
(119,881)
 
0
               
For the Period Ended September 30, 2008
 
As
     
As
     
Reported
 
Adjustment
 
Restated
Consolidated Statement of Changes in Stockholders' deficit
           
               
Net income ( loss)
 
 $
(7,010,864)
$
(771,937)
$
(7,782,801)
Accumulated deficit
 
  
(70,352,640)
 
(771,937)
 
(71,124,577)
Total stockholders’ deficit
  
(17,553,180)
 
(771,937)
 
(18,325,117)


Section 9 — Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Letter from MaloneBailey, LLC dated June 16, 2010

 
 

 


SIGNATURES
 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
 


   
EARTH SEARCH SCIENCES, INC.
     
Dated:   August 16, 2010
By:  
//s// Tami Story                                     
   
Tami Story
Corporate Secretary
 
 
 
 
 
 
 

 

Earth Search Sciences (CE) (USOTC:ESSE)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024 Click aqui para mais gráficos Earth Search Sciences (CE).
Earth Search Sciences (CE) (USOTC:ESSE)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024 Click aqui para mais gráficos Earth Search Sciences (CE).